FOXO4-DRI Where to Buy: The Only Channel That Exists

Summary: Every route you would normally use to obtain a medicine is closed for FOXO4-DRI, not because it is restricted but because nothing has ever been approved, so the research-supply channel is the only one that exists.

This content is for informational purposes only and is not medical advice. Always consult a qualified healthcare provider before starting, changing, or stopping any medication.

FOXO4-DRI where to buy has a shorter answer than most people expect: research-peptide suppliers, and nowhere else. Not because the compound is controlled or restricted, but because it has never been approved anywhere, so there is no product for a pharmacy to stock and no prescription for a doctor to write [2].

Where readers actually buy it

Ascension Peptides — FOXO4-DRI

Research-grade FOXO4-DRI, tested by two outside labs and shipped from the US. The code below takes half off the vial.

Code at checkoutPEPTIDEDECK50% off
FOXO4-DRI · 10 mg$134.00$67.00$6.70/mgGet the 10 mg →

The two published certificates cover different batches and disagree on net content: Kovera Labs assayed batch 55-05260628 at 11.41 mg and MZ Biolabs assayed lot 55-01260229 at 8.30 mg, both against a 10 mg label, which moves the real figure between $5.87 and $8.07/mg. Endotoxin and sterility screens appear on the Kovera batch only. The vendor spells the product FOX04 with a zero, including in the link. Buying 3, 5 or 10 takes 3%, 5% or 10% off the list price. Free shipping starts at $250.

  • Batch certificates from two independent labs
  • Free shipping over $250
  • Ships same day if ordered before 2pm CST

Every normal route, and why each one is closed

If you have obtained semaglutide or tirzepatide, you used a system: a prescriber decided it was appropriate, a pharmacy dispensed an approved product with a label, and an insurer either paid or did not. Run FOXO4-DRI through that system and every step fails, for the same underlying reason.

RouteAvailableWhy not
Retail pharmacy with a prescriptionNoNothing approved exists to dispense
Telehealth programmeNoA prescriber cannot write for an unapproved compound
Compounding pharmacyNoNot on any bulk substance list for compounding
Longevity clinic or med spaNot lawfullyAny stock is research-grade or a different compound
Overseas online pharmacyNoSame absence of approval, plus customs exposure
Research-peptide supplierYesSold as laboratory material, the only channel there is

The pattern is one fact repeated: no marketing authorisation from the FDA, the EMA or the MHRA. Approval is what creates a label, an indication, a dose and a supply chain. Without it, none of those things exist to be accessed.

That is also why FOXO4-DRI has no established dose, which surprises people who assume the information is out there somewhere. Doses come from human trials. There have been none.

What "research use only" actually means

Every legitimate listing carries this phrase, and it is worth understanding rather than treating as a formality to scroll past.

It means the material is sold as a laboratory reagent, not a medicine. The seller is not claiming it is safe, effective, or suitable for a person, and is not permitted to. There is no prescriber assessing your situation, no pharmacist checking interactions, and no adverse-event reporting pathway if something goes wrong.

It also tells you something useful about the vendor. Marketing an unapproved compound for human use is not lawful, so a seller who does it anyway has shown you how they treat rules generally. That matters, because the same vendor is the only source of the batch documentation you would rely on. A supplier relaxed about the first thing is rarely rigorous about the second.

How to choose between suppliers

Since research supply is the only channel, the real decision is which supplier, and price is close to the least informative signal available.

What actually separates them is whether you can verify the contents of the vial. A batch-specific certificate naming the lot stamped on your vial, from a laboratory with a real name and address. Purity measured by HPLC and identity confirmed by mass spectrometry, because purity alone does not tell you the molecule is the right one. A stated net content figure, which is a different measurement from purity and the one almost nobody publishes. Domestic dispatch, so customs is not in the path and a return address is real.

A vial priced well below the market with no lot number and no named laboratory is not a bargain. It is unidentified powder at a discount, and there is no practical way for a buyer to find out otherwise.

What the published certificates show

Ascension is the supplier we point readers to, and the reason is that it publishes enough to be checked. Checking it produces one genuinely useful finding.

Two laboratories have certified this product, on two different batches, and they disagree about how much peptide is in the vial. Kovera Labs certified batch 55-05260628 in June 2026 at 99.411% purity, with a measured net content of 11.41 mg. MZ Biolabs analysed lot 55-01260229 in January 2026 at 99.97% purity, with a measured net content of 8.30 mg. Both vials were labelled 10 mg.

Neither report is defective. Purity and quantity are separate measurements and both purity figures were excellent. But one batch came in roughly 14% above the labelled mass and the other roughly 17% below it, a spread no headline price reflects. At $67.00 with the code, the real cost moves between about $5.87 and $8.07 per milligram.

We would rather publish that than a cleaner story. A supplier that measures fill at all is doing more than most of this market, and the honest way to treat that disclosure is to report what it says.

Before you buy anything, know what the evidence is

The compound has a real mechanism and a striking result behind it. It also has a gap where human evidence would be.

FOXO4-DRI disrupts the interaction between the FOXO4 protein and p53 inside senescent cells, which allows those cells to undergo apoptosis while healthy cells are largely spared. The 2017 study reported that treated mice recovered fitness, fur density and renal function, and that the peptide reduced chemotherapy toxicity [1]. Those are genuine findings in mice.

Nine years later there is still no registered human trial. Preclinical results failing to reproduce in people is the ordinary outcome of drug development, not an unlucky exception.

Senolysis is also not automatically beneficial. Senescent cells suppress tumour formation and assist wound healing, and a 2023 study found that clearing them could worsen pulmonary hypertension [3]. Anyone presenting this class as risk-free is not describing the literature. If you are comparing research-peptide suppliers more broadly, the BPC-157 buying guide covers the same vendor-assessment ground.

Where can you buy FOXO4-DRI?
From research-peptide suppliers, sold as laboratory material. There is no pharmacy or clinic route, because FOXO4-DRI has no marketing authorisation anywhere and no approved product exists to dispense.
Can a doctor prescribe FOXO4-DRI?
No. A prescription is an instruction to a pharmacy to supply an approved product, and none exists for this compound. That is not a restriction on doctors; there is simply nothing approved to prescribe.
Is it legal to buy FOXO4-DRI?
In the United States it is legal to buy and sell as research material, which is the basis on which suppliers list it. Marketing it for human use is not lawful. Importing into the UK or EU adds customs and regulatory risk carried by the buyer.
What should I check before ordering?
A batch-specific certificate naming the lot on your vial, a named testing laboratory, both purity and identity methods, a stated net content figure, and domestic dispatch. Absence of human-use claims on the listing is also a signal worth weighting.
Why do the two certificates disagree about the amount?
Because they cover different batches and measure different properties. Purity and net content are separate. Both batches tested above 99% pure, but one held 11.41 mg and the other 8.30 mg against the same 10 mg label.

References

  1. Baar MP et al, Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging, Cell 2017
  2. FDA, Unapproved Drugs
  3. Eliminating Senescent Cells Can Promote Pulmonary Hypertension Development and Progression, Circulation 2023